Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in patients with chronic pulmonary diseases

References

• Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. Semin Respir Crit Care Med 2005; 26:563 - 74; http://dx.doi.org/10.1055/s-2005-925523; PMID: 16388428
   PubMed Web of Science ®Google Scholar
• Torres A, Dorca J, Zalacaín R, Bello S, El-Ebiary M, Molinos L, et al. Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study. Am J Respir Crit Care Med 1996; 154:1456 - 61; PMID: 8912764
   PubMed Web of Science ®Google Scholar
• COPD Guidelines Group of the Standards of Care Committee of the BTS. BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52:S7 - 15
   Web of Science ®Google Scholar
• National Institute of Clinical Excellence. COPD: National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59:Suppl 1 181 - 272; PMID: 14985544
   PubMedGoogle Scholar
• GOLD Executive Committee. Global strategy for diagnosis, management, and prevention of COPD [updated 2008]. Available from: http://www.goldcopd.com/ 2008.
   Google Scholar
• Fine MJ, Smith MA, Carson CA, Meffe F, Sankey SS, Weissfeld LA, et al. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154:2666 - 77; http://dx.doi.org/10.1001/archinte.1994.00420230051007; PMID: 7993150
   PubMed Web of Science ®Google Scholar
• Melegaro A, Edmunds WJ. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 2004; 19:353 - 63; http://dx.doi.org/10.1023/B:EJEP.0000024701.94769.98; PMID: 15180106
   PubMed Web of Science ®Google Scholar
• Moberley SA, Holden J, Tatham DP, Andrews RM. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; CD000422; PMID: 18253977
   PubMedGoogle Scholar
• Huss A, Scott P, Stuck AE, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180:48 - 58; http://dx.doi.org/10.1503/cmaj.080734; PMID: 19124790
   PubMed Web of Science ®Google Scholar
• Walters JA, Smith S, Poole PJ, Granger RH, Wood-Baker R, Cates CJ, et al. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010; 11:CD001390; PMID: 21069668
   PubMed Web of Science ®Google Scholar
• Walters JA, Smith S, Poole P, Granger RH, Wood-Baker R. Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2010; 11:CD001390; PMID: 21069668
   PubMed Web of Science ®Google Scholar
• Gutiérrez F, Masí M, Rodríguez JC, Ayelo A, Soldán B, Cebrín L, et al. Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain. Clin Infect Dis 2003; 36:286 - 92; http://dx.doi.org/10.1086/345852; PMID: 12539069
   PubMed Web of Science ®Google Scholar
• Rosón B, Ferńndez-Sabé N, Carratalà J, Verdaguer R, Dorca J, Manresa F, et al. Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia. Clin Infect Dis 2004; 38:222 - 6; http://dx.doi.org/10.1086/380639; PMID: 14699454
   PubMed Web of Science ®Google Scholar
• Alfageme I, Vazquez R, Reyes N, Muñoz J, Ferńndez A, Hernandez M, et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 2006; 61:189 - 95; http://dx.doi.org/10.1136/thx.2005.043323; PMID: 16227328
   PubMed Web of Science ®Google Scholar
• Nichol KL, Baken L, Wuorenma J, Nelson A. The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease. Arch Intern Med 1999; 159:2437 - 42; http://dx.doi.org/10.1001/archinte.159.20.2437; PMID: 10665892
   PubMed Web of Science ®Google Scholar
• Franzen D. Clinical efficacy of pneumococcal vaccination--a prospective study in patients with longstanding emphysema and/or bronchitis. Eur J Med Res 2000; 5:537 - 40; PMID: 11147998
   PubMedGoogle Scholar
• Ochoa-Gondar O, Vila-Corcoles A, Ansa X, Rodriguez-Blanco T, Salsench E, de Diego C, et al, EVAN Study Group. Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study. Vaccine 2008; 26:1955 - 62; http://dx.doi.org/10.1016/j.vaccine.2008.02.021; PMID: 18343541
   PubMed Web of Science ®Google Scholar
• Lee TA, Weaver FM, Weiss KB. Impact of pneumococcal vaccination on pneumonia rates in patients with COPD and asthma. J Gen Intern Med 2007; 22:62 - 7; http://dx.doi.org/10.1007/s11606-007-0118-3; PMID: 17351841
   PubMed Web of Science ®Google Scholar
• Sumitani M, Tochino Y, Kamimori T, Fujiwara H, Fujikawa T. Additive inoculation of influenza vaccine and 23-valent pneumococcal polysaccharide vaccine to prevent lower respiratory tract infections in chronic respiratory disease patients. Intern Med 2008; 47:1189 - 97; http://dx.doi.org/10.2169/internalmedicine.47.0799; PMID: 18591839
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep 2010; 59:1102 - 6; PMID: 20814406
   PubMedGoogle Scholar
• Sisk JE, Moskowitz AJ, Whang W, Lin JD, Fedson DS, McBean AM, et al. Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA 1997; 278:1333 - 9; http://dx.doi.org/10.1001/jama.1997.03550160053038; PMID: 9343464
   PubMed Web of Science ®Google Scholar
• Evers SM, Ament AJ, Colombo GL, Konradsen HB, Reinert RR, Sauerland D, et al. Cost-effectiveness of pneumococcal vaccination for prevention of invasive pneumococcal disease in the elderly: an update for 10 Western European countries. Eur J Clin Microbiol Infect Dis 2007; 26:531 - 40; http://dx.doi.org/10.1007/s10096-007-0327-z; PMID: 17570001
   PubMed Web of Science ®Google Scholar
• Hak E, Grobbee DE, Sanders EA, Verheij TJ, Bolkenbaas M, Huijts SM, et al. Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med 2008; 66:378 - 83; PMID: 18990781
   PubMed Web of Science ®Google Scholar
• Vila-Córcoles A, Ochoa-Gondar O, Ester F, Sarrá N, Ansa X, Saún N, EVAN Study Group. Evolution of vaccination rates after the implementation of a free systematic pneumococcal vaccination in Catalonian older adults: 4-years follow-up. BMC Public Health 2006; 6:231; http://dx.doi.org/10.1186/1471-2458-6-231; PMID: 16981982
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Salsench E, Rodriguez-Blanco T, Ochoa-Gondar O, de Diego C, Valdivieso A, et al. Clinical effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia in middle-aged and older adults: a matched case-control study. Vaccine 2009; 27:1504 - 10; http://dx.doi.org/10.1016/j.vaccine.2009.01.013; PMID: 19171174
   PubMed Web of Science ®Google Scholar
• Hosmer DW, Lemeshow SA. Applied Logistic Regression. 2nd ed. New York, NY: John Wiley & Sons, Inc.; 2000. p. 223-259.
   Google Scholar